Cetera Advisors LLC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 195 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.61 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cetera Advisors LLC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$374,452
-14.7%
48,192
+6.2%
0.01%
-14.3%
Q2 2023$439,124
-9.6%
45,364
+2.4%
0.01%
-12.5%
Q1 2023$485,517
+218.4%
44,299
+25.5%
0.01%
+166.7%
Q4 2022$152,496
-42.5%
35,3000.0%0.00%
-57.1%
Q3 2022$265,000
-24.7%
35,300
+0.9%
0.01%
-12.5%
Q2 2022$352,000
-10.4%
35,000
+10.2%
0.01%0.0%
Q1 2022$393,000
-36.8%
31,749
+16.7%
0.01%
-38.5%
Q4 2021$622,000
-0.6%
27,199
-3.8%
0.01%
+8.3%
Q3 2021$626,000
+298.7%
28,268
+133.5%
0.01%
+200.0%
Q2 2021$157,00012,1050.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Berry Street Capital Management LLP 1,987,500$24,605,0002.79%
NEA Management Company, LLC 3,969,834$49,146,0001.42%
IRONWOOD INVESTMENT MANAGEMENT LLC 133,117$1,648,0000.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 435,000$3,955,0000.89%
ACT CAPITAL MANAGEMENT, LLC 67,500$836,0000.88%
Artal Group S.A. 1,000,000$12,380,0000.52%
CTC Capital Management, LLC 12,800$158,0000.42%
KESTRA PRIVATE WEALTH SERVICES, LLC 581,910$7,204,0000.36%
Affinity Asset Advisors, LLC 175,000$2,167,0000.35%
Bellevue Group AG 2,405,825$29,784,0000.35%
View complete list of AURINIA PHARMACEUTICALS INC shareholders